Shuwen Biotech

Shuwen Biotech is an integrated diagnostic company specializing in precision medicine and women's health. It develops and commercializes innovative IVD kits and laboratory services focused on oncology—especially breast and ovarian cancers—and reproductive/maternal-fetal medicine. The company has developed proprietary technologies such as the Fudan Subtyping method for triple-negative breast cancer in partnership with academic institutions. Its portfolio includes both marketed products and a robust pipeline of new diagnostic assays. Clinical results from its Fudan subtyping technology have shown improved response rates when used to guide personalized treatment in prospective trials.